The Study Although Obstructive sleep apnea (OSA) is a very common condition that is associated with an increased risk of cardiovascular disease (CVD), there is much uncertainty over the effectiveness of treatment with nasal continuous positive airway pressure (CPAP) for the prevention of CVD. The SAVE trial was a multi-centre, open label, parallel, prospective, randomised, […]
Read More
Utilizing key therapeutic knowledge leader networks as championed by George Clinical has again shown its effectiveness in boosting recruitment; this time for a Phase 1 renal patient trial. It is widely understood that the recruitment of patients into a Phase 1 trial can be fraught with difficulty. This difficulty arises from: A lack of established […]
Read More
Background George Clinical provides scientific leadership to clinical trials, where peer-to-peer engagement from clinicians is leveraged to facilitate study operations. In the traditional study operations model, clinical research associates (CRAs) typically engage with site personnel, such as study coordinators, on a day-to-day basis. Principal investigators, whose expertise and seniority at the site’s operational hierarchy, is […]
Read More
The Study George Clinical (GC) is collaborating with a global, research-based biopharmaceutical company to evaluate the effect of a new chemical entity in subjects with type 2 diabetes and nephropathy. George Clinical services GC is responsible for project management (PM) and monitoring throughout the Asia-Pacific. Other regions were managed by a separate contract research organization […]
Read More
The Study George Clinical (GC) collaborated with a mid-sized global pharmaceutical company to conduct a randomized trial comparing pain relief medication for patients with moderate to severe chronic cancer pain. George Clinical services GC was responsible for project management (PM) and monitoring across 26 sites in China. Study sites were located in Beijing, Changchun, Dalian, […]
Read More
With the support of George Clinical (GC), The George Institute (TGI) for Global Health conducted a longitudinal cohort study of approximately 9,500 hospital patients with a first time diagnosis of cancer. The study was conducted across eight countries, namely: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Thailand and Vietnam. The aim of the study was to […]
Read MoreGeorge Clinical has recently been awarded the contract for full service clinical trial management services for a clinical study that seeks to improve the formulation further and also the current administration challenges for a rotavirus vaccine. The vaccine was recently launched by Indian Prime Minister Narendra Modi and developed by a Hyderabad based healthcare organization […]
Read MoreThe World Health Organization estimates that 347 million people worldwide have diabetes, and that number is expected to continue increasing as more people move to urban cities and the population ages. Low and middle-income countries, like China and India, have been hit hardest with this disease and other NCDs. In 2010, the total number of […]
Read MoreIntracerebral hemorrhage is the most serious form of stroke with high rates of mortality and a low chance of recovery to functional independence. In Asia Pacific, it affects more than one million people annually, kills one third of them and leaves most survivors with disability. For reasons yet unknown, intracerebral hemorrhage is also more prevalent […]
Read MoreDiseases that dominate the 21st century need a 21st century approach in the way we design and conduct clinical trials. To meet this need, George Clinical is primarily focused on large-scale studies with high-impact outcomes, particularly where smaller pre-registration trials need to be expanded to larger populations. George Clinical has been managing clinical trials in […]
Read More
